TrialAnnals of the rheumatic diseases2018

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).

Yuko Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.